“We often have to rely on imaging or endoscopy to distinguish between organic and functional GI diseases but this can be expensive and invasive and does not help with the differentiation of functional GI diseases,” said AJG Co-Editor-in-Chief Paul Moayyedi, MD, FACG.
Studies in the issue address how biomarkers can play a role in the treatment of inflammatory bowel disease, liver disease, pancreatic cysts and more.
More articles on gastroenterology:
Consumerism is taking healthcare by storm: How is GI affected?
EndoChoice IPO update: Common stock price set at $15 per share
Frisbie Memorial Hospital begins to offer virtual colonoscopy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
